BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Cellceutix Provides Initial Observations Of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application To FDA For Phase 2 Trial Of Brilacidin-OM For Oral Mucositis

  September 10, 2014

   · 

  7 min read
• Business

  Peregrine Pharmaceuticals, Inc. Reports First Quarter Fiscal Year 2015 Financial Results And Recent Developments

  September 10, 2014

   · 

  17 min read
• Biotech Bay

  Stanford StartX & Mission Bay Capital Invest $1.86 Million In University of California, Berkeley (CAL) Spin-out For Single Cell Analysis

  September 10, 2014

   · 

  1 min read
• Pharm Country

  BrainStorm Cell Therapeutics Inc. Provides Update On NASDAQ Uplisting Process

  September 10, 2014

   · 

  4 min read
• Business

  Sensiotec Inc. And WellStar Health System’s Center For Health Transformation Announce Formal Agreement On Virtual Medical Assistant®

  September 10, 2014

   · 

  5 min read
• Transcatheter Technologies Will Report One-Year Follow-Up Results For Study Of Its “Truly Repositionable” Trinity TAVI System At “TCT 2014" In Washington, DC

  September 10, 2014

   · 

  2 min read
• Business

  Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal

  September 10, 2014

   · 

  2 min read
• BioMidwest

  Siloam Biosciences Receives A $1 Million Phase II SBIR Contract To Develop An Immunodiagnostic System Using Only ¼ Of A Drop Of Blood For Cancer Tests

  September 10, 2014

   · 

  3 min read
• Business

  Afferent Pharmaceuticals Names Kathleen Sereda Glaub As Chief Executive Officer

  September 10, 2014

   · 

  4 min read
• Business

  Durham’s Liquidia Technologies Inc. Spins Out Second Pharmaceutical Company; Raises $10 Million From Bay Area VC Firm

  September 10, 2014

   · 

  3 min read